Trendlines Group Ltd. · SGX:42T
Trendlines — The Trendlines Group — Investor Presentation (February 2025)
19 slides from Trendlines's investor presentation, February 2025
Slide 1: Succeeding Together
Succeeding Together Transforming futures in medtech & agrifood Haim Brosh, CEO & Interim CFO | February 2025
Slide 2: Legal disclaimer
Legal disclaimer Important notice This presentation is for informational purposes only and does not constitute or form any part of any offer for sale or subscription of, or solicitation of, any offer to buy or subscribe for any securities of The Trendlines Group Ltd. (“Company”) or any of its portfo
Slide 3: Who we are
Who we are We have established, built & continue to invest in our broad medtech and agrifood portfolio. Our goal is to achieve significant exits from our portfolio, bringing value to our shareholders. Trendlines is an Israel-headquartered company that trades in Singapore on the SGX (42T) and in the
Slide 4: Leadership
Leadership Haim Brosh Nitza Kardish PhD CEO and Interim CFO Trendlines Agrifood Steve Rhodes Founder & Chair Emeritus 25 years’ managerial Vast experience in food and financial and agriculture Trendlines’ Founder; over 40 experience in public technologies alongside years’ experience, deep and privat
Slide 5: Board of Directors
Board of Directors Nehama Ronen Elka Nir Chair External Director* 25 years’ experience 35 years’ experience in public companies. in technology She was Director management of General of Israel’s public and private Ministry of Environmental companies Protection Sin Boon Ann Professor Low Teck Seng Sar
Slide 6: A taste of our portfolio companies
A taste of our portfolio 42 companies * portfolio 14 28 agrifood medtech * including the 8 consolidated portfolio companies in Singapore 6
Slide 7: Portfolio cluster values
Portfolio cluster values Fair Value of Trendlines’ Non-IFRS* Value of Trendlines’ Share Cluster Share (US$'000) (additional information) (US$'000) Aquaculture & Animal Health US$ 3,481 US$ 3,992 Crop Protection US$ 5,627 US$ 12,802 Future Food & Ingredients US$ 11,065 US$ 18,794 Digitization & Robot
Slide 8: The natural food color revolution
The natural food color revolution A broad-spectrum of healthy plant-based colors produced via Founded 2018; fermentation technology, using baker’s yeast as a biofactory. 23 employees; Phytolon’s high-quality and cost-effective pigments offer value Yokne’am Illit, IL for consumers, the environment an
Slide 9: 4 more agrifood frontrunners
4 more agrifood frontrunners 14 agrifood portfolio companies Phage-based solutions for crop Cultivating high quality and high Nanobody-based biological insect Artificial intelligence analytics disease control that target bacteria value cocoa ingredients using cell control to uniquely target the empl
Slide 10: Cryotherapy treatment for urological tissue
Cryotherapy treatment for urological tissue A new ablative approach for the treatment of urological tissue with cryotherapy. Founded 2015 Achievements CEO Eyal Kochavi • Closed US$16.5 million investment round including IP Submitted national strategic partner participation phase and PCT • Ongoing cl
Slide 11: 4 more leading medtech companies
4 more leading medtech companies 28 medtech portfolio companies Minimally invasive, nonsurgical, Endoscopic ultrasound fine needle Next-generation aspiration catheter A small, game-changing incision-free and mesh-free repair biopsy system for improve, precise for treating ischemic stroke. device to
Slide 12: Let's look at the numbers
Let's look at the “= trendlines
Slide 13: FY 2024: Key Financial Metrics
FY 2024: Key Financial Metrics 31 December 2024 31 December 2023 Portfolio value: US$66.1 million US$66.4 million Total Equity: US$68.0 million US$69.1 million NAV per share: US$0.06 (S$0.08) US$0.07 (S$0.09) Net loss (US$10.2 million) (US$34.7 million) 13
Slide 14: Consolidated condensed report of income (Group)
Consolidated condensed report of income (Group) Consolidated statements of profit or loss (US$’000) 31 Dec 31 Dec Income Expenses 2024 2024 Gain from change in fair value of Operating, general and administrative (3,126) 8,657 investments in portfolio companies expenses Income from services to portfo
Slide 15: Balance sheet (Group)
Balance sheet (Group) Assets (US$’000) (US$’000) Current assets 31 Dec 2024 Non-current assets 31 Dec 2024 Cash and cash Investments in portfolio 4,971 66,101 equivalents companies Short-term bank Accounts and other 1,016 28 deposits receivables Accounts and other Right-of-use assets 1,765 777 recei
Slide 16: Balance sheet (Group)
Balance sheet (Group) Liabilities (US$’000) (US$’000) Current liabilities 31 Dec 2024 Long-Term liabilities 31 Dec 2024 Lease liability 304 Loans from the Israel Short-term loan 423 2,212 Innovation Authority Trade and other Lease liability 1,212 3,152 payables Other long-term Deferred revenues - 15
Slide 17: Latest portfolio news
Latest portfolio news For full details, see our news page 17
Slide 18: Thank you
THANK YOU Haim Brosh, CEO & Interim CFO - haim@trendlines.com | +972.72.260.7000 | www.trendlines.com
Slide 19: Notes and Disclaimer
Notes and Disclaimer The non-IFRS fair value information does not represent any forecast or future performance but serves as an extra aid in evaluating our portfolio companies and investment approaches. The additional information (Non-IFRS value) which, as stated, differs from the IFRS fair value at
The Trendlines Group — Investor Presentation (February 2025) on 6ix